RELIEF OF DIASTOLIC CARDIAC DYSFUNCTION AFTER CYCLOSPORINE WITHDRAWAL IN A CARDIAC TRANSPLANT RECIPIENT

被引:9
|
作者
SIOSTRZONEK, P
TEUFELSBAUER, H
KREINER, G
LACZKOVICS, A
GOSSINGER, H
HEINZ, G
STUMPFLEN, A
MOSSLACHER, H
机构
[1] UNIV VIENNA,DEPT MED 1,A-1090 VIENNA,AUSTRIA
[2] UNIV VIENNA,DEPT SURG 2,A-1090 VIENNA,AUSTRIA
关键词
CARDIAC TRANSPLANTATION; CYCLOSPORINE; HEART FAILURE;
D O I
10.1093/eurheartj/14.6.859
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe heart failure developed in a 49-year-old patient 18 months after orthotopic cardiac transplantation. Acute rejection as well as other overt causes of graft failure were excluded. Haemodynamic measurements suggested severe diastolic myocardial dysfunction. Since no other causes of diastolic heart failure were identified, a potential side effect from cyclosporine was considered. Cyclosporine was therefore withdrawn and immunosuppressive treatment was switched to conventional therapy consisting of azathioprine and prednisolone. Withdrawal of cyclosporine was followed by an impressive clinical improvement and by complete haemodynamic normalization. Therefore, in cases of otherwise unexplained graft failure, a potentially reversible side effect from cyclosporine should be taken into consideration. © 1993 The European Society of Cardiology.
引用
收藏
页码:859 / 861
页数:3
相关论文
共 50 条
  • [11] Cardiac Remodeling and Diastolic Dysfunction in Paroxysmal Atrial Fibrillation
    Noirclerc, Nathalie
    Huttin, Olivier
    de Chillou, Christian
    Selton-Suty, Christine
    Fillipetti, Laura
    Sellal, Jean Marc
    Bozec, Erwan
    Donal, Erwan
    Lamiral, Zohra
    Kobayashi, Masatake
    Ferreira, Joao Pedro
    Rossignol, Patrick
    Girerd, Nicolas
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [12] Parvalbumin: Targeting calcium handling in cardiac diastolic dysfunction
    Wang, Wang
    Martindale, Joshua
    Metzger, Joseph M.
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2009, 28 : F3 - F6
  • [13] Characterization of Aging-Associated Cardiac Diastolic Dysfunction
    Chang, Wei-Ting
    Chen, Jung-San
    Hung, Yung-Kung
    Tsai, Wei-Chuan
    Juang, Jer-Nan
    Liu, Ping-Yen
    PLOS ONE, 2014, 9 (05):
  • [14] Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction
    Jia, Guanghong
    Jia, Yan
    Sowers, James R.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (08): : 2012 - 2018
  • [15] Diastolic dysfunction, diagnostic and perioperative management in cardiac surgery
    Nicoara, Alina
    Swaminathan, Madhav
    CURRENT OPINION IN ANESTHESIOLOGY, 2015, 28 (01) : 60 - 66
  • [16] Causality, Correlation, and Cardiac Disease: Does Smoking Cause Cardiac Hypertrophy and Diastolic Dysfunction?
    Leary, Peter J.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2016, 9 (09)
  • [17] Management of the cardiac transplant recipient: Roles of the transplant cardiologist and primary care physician
    Wagoner, LE
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (03) : 173 - 184
  • [18] VASODEPRESSOR SYNCOPE IN A CARDIAC TRANSPLANT RECIPIENT - A CASE OF VAGAL REINNERVATION
    RUDAS, L
    PFLUGFELDER, PW
    KOSTUK, WJ
    CANADIAN JOURNAL OF CARDIOLOGY, 1992, 8 (04) : 403 - 405
  • [19] Myocardial Titin and Collagen in Cardiac Diastolic Dysfunction: Partners in Crime
    Hamdani, Nazha
    Paulus, Walter J.
    CIRCULATION, 2013, 128 (01) : 5 - 8
  • [20] Gestational hypertension and the developmental origins of cardiac hypertrophy and diastolic dysfunction
    Armstrong, David W. J.
    Tse, M. Yat
    Wong, Philip G.
    Ventura, Nicole M.
    Meens, Jalna A.
    Johri, Amer M.
    Matangi, Murray F.
    Pang, Stephen C.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 391 (1-2) : 201 - 209